Denali Therapeutics Inc. (DNLI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Denali Therapeutics Inc.

NASDAQ: DNLI · Real-Time Price · USD
15.42
0.22 (1.45%)
At close: Oct 03, 2025, 3:59 PM
15.26
-1.04%
After-hours: Oct 03, 2025, 07:56 PM EDT

Denali Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
174.96M 127.11M 218.04M 293.48M
Short-Term Investments
657.37M 907.4M 1.12B 571.93M
Long-Term Investments
359.37M n/a 1.5M 425.45M
Other Long-Term Assets
24.74M 18.14M 11.9M 11.87M
Receivables
2.17M 3.42M 9.28M 1.23M
Inventory
n/a n/a -5M n/a
Other Current Assets
30.61M n/a n/a n/a
Total Current Assets
864.44M 1.06B 1.37B 897.23M
Property-Plant & Equipment
125.63M 71.64M 74.52M 69.61M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
509.74M 89.78M 87.92M 506.93M
Total Assets
1.37B 1.15B 1.46B 1.4B
Account Payables
11.14M 9.48M 2.79M 4.78M
Deferred Revenue
n/a n/a 290.05M 320.3M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
66.34M 21.59M 46.67M 28.7M
Total Current Liabilities
102.21M 77.98M 363.92M 378.25M
Long-Term Debt
42.29M n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 379K 379K
Total Long-Term Liabilities
42.29M 44.98M 53.89M 63.63M
Total Liabilities
144.5M 122.96M 417.81M 441.87M
Total Debt
48.71M 52.24M 60.35M 58.55M
Book Value
1.23B 1.03B 1.04B 962.29M
Book Value Per Share
7.48 7.50 8.30 7.92
Common Stock
1.77M 1.71M 1.69M 1.55M
Retained Earnings
-1.54B -1.12B -970.99M -645M
Comprehensive Income
2.02M 643K -6.89M -2.5M
Shareholders Equity
1.23B 1.03B 1.04B 962.29M
Total Investments
1.02B 907.4M 1.12B 997.38M